Bayesian data monitoring in clinical trials

Statistics in Medicine

Volumn 16, Issue 12, 1997, Pages 1413-1430

  Fayers, Peter M ^a,c   Ashby, Deborah ^b   Parmar, Mahesh K B ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYES THEOREM; CLINICAL TRIAL; ESOPHAGUS CARCINOMA; HUMAN; INFORMATION PROCESSING; MORTALITY; SURVIVAL; ADJUVANT CHEMOTHERAPY; COMPARATIVE STUDY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; MULTIMODALITY CANCER THERAPY; PROPORTIONAL HAZARDS MODEL; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME;

BAYES THEOREM; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DATA INTERPRETATION, STATISTICAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; LIKELIHOOD FUNCTIONS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031591552     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19970630)16:12<1413::AID-SIM578>3.0.CO;2-U     Document Type: Article

References (20)

1. Spiegelhalter, D. J., Freedman, L. S. and Parmar, M. K. B. 'Bayesian approaches to randomised trials', Journal of the Royal Statistical Society, Series A, 157, 357-416 (1994).
2. Parmar, M. K. B., Spiegelhalter, D. J. and Freedman, L. S. 'The CHART trials: Bayesian design and monitoring in practice', Statistics in Medicine, 13, 1297-1312 (1994).
3. Abrams, K., Ashby, D. and Errington, D. 'Simple Bayesian analysis in clinical trials: a tutorial', Controlled Clinical Trials, 15, 349-359 (1994).
4. Freedman, L. S. and Spiegelhalter, D. J. 'Application of Bayesian statistics to decision making during a clinical trial', Statistics in Medicine, 11, 23-25 (1992).
5. Freedman, L. S. and Spiegelhalter, D. J. 'Comparison of Bayesian with group sequential methods for monitoring clinical trials', Controlled Clinical Trials, 10, 357-367 (1989).
6. Freedman, L. S. and Spiegelhalter, D. J. 'The assessment of subjective opinion and its use in relation to stopping rules for clinical trials', Statistician, 32, 153-160 (1983).
7. Pocock, S. J. Clinical Trials: A Practical Approach, Wiley, Chichester, 1983.
8. Pocock, S. J. 'Interim analyses for randomised clinical trials: the group sequential approach', Biometrics, 38, 153-162 (1982).
9. Fayers, P. M., Cook, P. A., Machin, D., Donaldson, N., Whitehead, J., Ritchie, R., Oliver, R. T. D. and Yuen, P. 'On the development of the Medical Research Council trial of alpha-interferon in metastatic renal carcinoma', Statistics in Medicine, 13, 2249-2260 (1994).
10. ICRF Clinical Trial Service Unit. ISIS 3 Protocol, CTSU, Radcliffe Infirmary, Oxford UK, 1989.
11. Parmar, M. K. B. and Machin, D. 'Monitoring clinical trials - experience of and proposals under consideration by the Cancer Therapy Committee of the British Medical Research Council', Statistics in Medicine, 12, 495-504 (1993).
12. O'Brien, P. C. and Fleming, T. R. 'A multiple testing procedure for clinical trials, Biometrics, 35, 549-556 (1979).
13. Berry, D. A. 'A case for Bayesianism in clinical trials', Statistics in Medicine, 12, 1377-1393 (1993).
14. Fayers, P. M. and Machin, D. 'Sample size: how many patients are necessary?', British Journal of Cancer, 72, 1-9 (1995).
15. Machin, D. and Campbell, M. J. Statistical Tables for the Design of Clinical Trials, Blackwell Scientific Publications, Oxford, 1987.
16. Machin, D., Campbell, M. J., Fayers, P. M. and Pinol, A. Sample Size Tables for Clinical Studies, Blackwell Science, Oxford, 1997.
17. Ashby, D. 'Preface: Papers from the conference on Methodological and Ethical Issues in Clinical Trials', Statistics in Medicine, 12, 1373-1374 (1993).
18. Grossman, J., Parmar, M. K. B., Spiegelhalter, D. J. and Freedman, L. S. 'A unified method for monitoring and analysing controlled trials', Statistics in Medicine, 13, 1815-1826 (1994).
19. Tsiatis, A. A. 'The assymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time', Biometrika, 68, 311-315 (1981).
20. Spiegelhalter, D. J., Freedman, L. S. and Parmar, M. K. B. 'Applying Bayesian thinking in drug development and clinical trials', Statistics in Medicine, 12, 1501-1511 (1993).